De Jong Russell, Spear Samuel
Brooke Army Medical Center, San Antonio, TX
Brooke Army Medical Center, San Antonio, TX; Uniformed Services University of the Health Sciences, Bethesda, MD.
Hyperacusis is an audiological disorder characterized by persistent oversensitivity and intolerance to everyday environmental sounds that are normally well-tolerated by most people. Patients with hyperacusis experience varying degrees of discomfort and impairments in day-to-day activities, resulting in poor quality of life. Hyperacusis is neither phonophobia nor misophonia. Phonophobia is a temporary sensitivity to sound secondary to migrainous attacks and is associated with other sensory aversions, all of which abate when the migraine resolves. Misophonia is an acquired adverse reaction to specific sounds, such as chewing or breathing, and may have an emotional component. The prevalence of hyperacusis ranges from 5.9% to 17.2%. Hyperacusis and tinnitus are strongly associated; 86% of patients with hyperacusis endorse tinnitus, and 40% of patients with tinnitus endorse hyperacusis. Historically, the diagnosis of hyperacusis has relied heavily on self-reporting, the Hyperacusis Questionnaire, the Loudness Discomfort Level test, and the Tinnitus Retraining Therapy interview. Hyperacusis is most commonly caused by cochlear damage and head trauma but is known to be associated with depression, anxiety, adverse medication reactions, hearing loss, and autoimmune disorders. The pathogenesis of hyperacusis is not fully understood but may be due to acoustic overexposure, resulting in increased central auditory pathway gain. So-called “third window” pathologies such as superior semicircular canal dehiscence, perilymphatic fistula, and stapes hypermobility have also been proposed as possible etiologies of hyperacusis. Regardless of etiology, multiple pathophysiologic theories for hyperacusis have been proposed. The most widely accepted etiologic theory of hyperacusis is the cochlear theory; cochlear damage from a variety of processes, including but not limited to Ménière disease, perilymphatic fistula, and noise-induced hearing loss, results in cochlear dysfunction and hyperacusis. Other theories are based on possible central nervous system origins of hyperacusis. The 5-hydroxytryptamine (5-HT, serotonin) hypothesis speculates that some cases of hyperacusis may share a common origin with other serotonin-related symptoms like photophobia and tinnitus; hyperacusis is common in patients with depression and migraine headaches, both of which are likely related to serotonin disturbances. Another theory hypothesizes that increased endogenous opioids may cause hyperacusis. Experiments in chinchillas correlated increased endogenous opioids with increased auditory sensitivities, possibly indicative of a physiological mechanism to increase auditory gain in fight-or-flight situations. Lastly, the central plasticity hypothesis states that long-term noise exposure, such as in factory workers, changes the level of the central gain phenomenon such that individuals can wholly or partially lose their stapedial reflex and not have any sound-dampening response, resulting in hyperacusis. Treatment for hyperacusis includes avoidance of noise stimuli, tinnitus retraining therapy, cognitive behavioral therapy, and gradual sound exposure therapy. However, insufficient evidence exists to identify these strategies as an effective treatment for hyperacusis. Newly observed stapes hypermobility in hyperacusis patients has led to a surgical treatment involving reinforcement of the oval and round windows to reduce transmission of mechanical energy to the inner ear. Autophony is defined as hearing one’s voice or other bodily functions such as pulse, eye movements, and limb movements as loud or distorted. Autophony is most often related to third window pathologies such as various semicircular canal dehiscence syndromes, perilymphatic fistula, or an enlarged vestibular aqueduct. The proposed mechanism of autophony is that energy of the offending bodily sounds is mechanically transmitted through a pathological third window directly into the cochlea, thus overriding sounds being transmitted by the outer and middle ear. It has been demonstrated that reinforcing the natural windows, usually only the round window, returns the labyrinthine system to 2 windows and may improve autophony. However, this approach has not been extensively studied, and results are varied. Systematic reviews have suggested that primary window reinforcement is best employed as a first-line, low-risk intervention in medically complex patients not suitable for more invasive management of third window pathologies, such as transmastoid or middle cranial fossa craniotomy approaches to superior semicircular canal dehiscence.
听觉过敏是一种听觉障碍,其特征是对大多数人通常能耐受的日常环境声音持续过度敏感和不耐受。听觉过敏患者在日常活动中会经历不同程度的不适和功能障碍,导致生活质量下降。听觉过敏既不是恐音症也不是恐音症。恐音症是偏头痛发作继发的对声音的暂时敏感,与其他感觉厌恶有关,当偏头痛缓解时,所有这些都会减轻。恐音症是对特定声音(如咀嚼或呼吸声)的后天不良反应,可能有情感成分。听觉过敏的患病率在5.9%至17.2%之间。听觉过敏与耳鸣密切相关;86%的听觉过敏患者认可耳鸣,40%的耳鸣患者认可听觉过敏。历史上,听觉过敏的诊断严重依赖自我报告、听觉过敏问卷、响度不适水平测试和耳鸣再训练疗法访谈。听觉过敏最常见的原因是耳蜗损伤和头部外伤,但已知与抑郁症、焦虑症、药物不良反应、听力损失和自身免疫性疾病有关。听觉过敏的发病机制尚未完全了解,但可能是由于声学过度暴露,导致中枢听觉通路增益增加。所谓的“第三窗”病变,如半规管上裂、外淋巴瘘和镫骨活动过度,也被认为是听觉过敏的可能病因。无论病因如何,已经提出了多种关于听觉过敏的病理生理理论。听觉过敏最广泛接受的病因理论是耳蜗理论;各种过程(包括但不限于梅尼埃病、外淋巴瘘和噪声性听力损失)导致的耳蜗损伤会导致耳蜗功能障碍和听觉过敏。其他理论基于听觉过敏可能的中枢神经系统起源。5-羟色胺(5-HT,血清素)假说推测,某些听觉过敏病例可能与其他血清素相关症状(如畏光和耳鸣)有共同起源;听觉过敏在抑郁症和偏头痛患者中很常见,这两者都可能与血清素紊乱有关。另一种理论假设内源性阿片类物质增加可能导致听觉过敏。对龙猫的实验表明,内源性阿片类物质增加与听觉敏感性增加相关,这可能表明在战斗或逃跑情况下增加听觉增益的生理机制。最后,中枢可塑性假说指出,长期噪声暴露(如工厂工人)会改变中枢增益现象的水平,使个体完全或部分失去镫骨反射,且没有任何声音衰减反应,从而导致听觉过敏。听觉过敏的治疗包括避免噪声刺激、耳鸣再训练疗法、认知行为疗法和逐渐声音暴露疗法。然而,没有足够的证据将这些策略确定为听觉过敏的有效治疗方法。在听觉过敏患者中新观察到的镫骨活动过度导致了一种手术治疗,即加强椭圆窗和圆窗,以减少机械能向内耳的传递。自听增强被定义为听到自己的声音或其他身体功能(如脉搏、眼球运动和肢体运动)声音过大或失真。自听增强最常与第三窗病变有关,如各种半规管裂综合征、外淋巴瘘或扩大的前庭导水管。自听增强的 proposed 机制是,有害身体声音的能量通过病理性第三窗机械地直接传递到耳蜗,从而覆盖了由外耳和中耳传递的声音。已经证明,加强天然窗(通常只加强圆窗)可使迷路系统恢复到两个窗,并可能改善自听增强。然而,这种方法尚未得到广泛研究,结果也各不相同。系统评价表明,对于不适合采用更具侵入性的第三窗病变管理方法(如经乳突或中颅窝开颅手术治疗半规管上裂)的医学复杂患者,原发性窗强化最好作为一线低风险干预措施使用。